LNA Santé SA

EPA:LNA.PA

23.65 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42009 Q4
Revenue 372.411363.674368.342359.882351.346338.146295.598278.295272.384255.476278.348260.413244.426242.245254.514220.503202.388222.43175.693180.481159.962164.208000000
Cost of Revenue 289.313322.289316.882312.064283.851301.914255.17237.448231.128213.171197.625168.485172.424158.731172.304144.417130.17149.471112.54121.157104.299116.309000000
Gross Profit 83.09841.38551.4647.81867.49536.23240.42840.84741.25642.30580.72391.92872.00283.51482.2176.08672.21872.95963.15359.32455.66347.899000000
Gross Profit Ratio 0.2230.1140.140.1330.1920.1070.1370.1470.1510.1660.290.3530.2950.3450.3230.3450.3570.3280.3590.3290.3480.292000000
Reseach & Development Expenses 0000000000000000000000000000
General & Administrative Expenses 0000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 41.8262.75415.75211.9725.27611.3948.5318.1438.6087.47855.17952.02843.92549.10948.81145.14945.71942.92839.72136.93835.42329.892000000
Other Expenses -16.553-15.128-16.141-15.642-10.572-10.937-13.385-8.855-5.936-8.547000000000000000000
Operating Expenses 58.37917.88231.89327.61235.84822.33121.91616.99814.54416.02559.53571.0453.73563.59765.03558.9358.60255.61855.61348.49745.21138.005000000
Operating Income 24.71923.50319.56720.20631.64713.90118.51223.84926.71226.2823.18221.18623.32820.20622.13818.01617.84217.12115.45411.57114.52110.358000000
Operating Income Ratio 0.0660.0650.0530.0560.090.0410.0630.0860.0980.1030.0830.0810.0950.0830.0870.0820.0880.0770.0880.0640.0910.063000000
Total Other Income Expenses Net -6.196-4.7091.871.536-12.893.593-6.45-17.269-8.909-7.691-5.167-3.497-8.791-3.593-9.018-4.509-8.587-4.229-12.259-5.026-7.572-3.826000000
Income Before Tax 18.52318.79421.43721.74218.75717.49412.0626.5817.80318.64318.01517.68914.53716.61313.1213.5079.25512.8923.1956.5456.9496.532000000
Income Before Tax Ratio 0.050.0520.0580.060.0530.0520.0410.0240.0650.0730.0650.0680.0590.0690.0520.0610.0460.0580.0180.0360.0430.04000000
Income Tax Expense 6.586.4427.8968.0197.6846.96.3493.8567.2837.4766.7596.5080.2876.2881.5245.4023.7027.010.0062.6962.5713.068000000
Net Income 11.47611.93312.26513.54812.36511.1455.2982.50910.02310.80510.79110.73414.20110.0214.0117.6115.0995.5243.1663.8654.3343.381000000
Net Income Ratio 0.0310.0330.0330.0380.0350.0330.0180.0090.0370.0420.0390.0410.0580.0410.0550.0350.0250.0250.0180.0210.0270.021000000
EPS 1.121.161.171.321.291.160.550.261.041.121.121.111.471.041.540.850.570.520.370.450.510.4000000
EPS Diluted 1.121.161.171.311.291.160.550.261.041.121.121.111.471.041.540.850.570.520.370.450.510.4000000
EBITDA 64.98863.28358.52158.82269.54551.3853.84654.25856.11954.84831.09825.32229.87726.21427.25923.42324.96420.7129.21516.71121.13214.479000000
EBITDA Ratio 0.1750.1740.1590.1630.1980.1520.1820.1950.2060.2150.1120.0970.1220.1080.1070.1060.1230.0930.1660.0930.1320.088000000